An­oth­er safe­ty in­ci­dent trig­gers a halt to a piv­otal Covid-19 vac­cine study as J&J slams on the brakes

John­son & John­son has vol­un­tar­i­ly or­dered a halt to all of its Covid-19 vac­cine stud­ies so in­ves­ti­ga­tors can probe the un­ex­plained ill­ness of one of the peo­ple in their study.

In a state­ment put out Mon­day evening, the phar­ma gi­ant said that it had paused fur­ther dos­ing, not­ing that “the par­tic­i­pant’s ill­ness is be­ing re­viewed and eval­u­at­ed by the EN­SEM­BLE in­de­pen­dent Da­ta Safe­ty Mon­i­tor­ing Board as well as our in­ter­nal clin­i­cal and safe­ty physi­cians.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER